The location of CARD8 within an inflammatory bowel disease (IBD) locus and its role in the NALP3 inflammasome and as a nuclear factor (NF)kB inhibitor make it an attractive candidate risk gene for IBD. However, studies testing for the association of the CARD8 loss-of-function single-nucleotide polymorphism (SNP) rs2043211 with IBD have yielded mixed results. A recent study provided evidence that this discordance may result from an interaction of rs2043211 with loss-offunction variants in nucleotide-binding oligomerization domain protein 2 (NOD2) and a gain-of-function SNP (rs35829419) in NALP3. To confirm this interaction, we conducted a replication in an independent IBD sample set (n ¼ 1009 patients, n ¼ 517 controls). We found that the presence of the minor allele of rs2043211 with the major allele of rs35829419 conferred a protective effect against Crohn's disease (and vice versa), which intensified in the absence of NOD2 mutations (P 1,2/1,1 ¼ 0.009, odds ratio (OR) ¼ 0.66, 95% confidence interval (CI) (0.48-0.90); P 1,1/1,2 ¼ 0.015, OR ¼ 0.35, 95% CI (0.15-0.82)). We propose that these genotype combinations protect against gut inflammation by preventing the NALP3 inflammasome from producing excessive interleukin-1b.
Introduction
The CARD8 gene (also known as TUCAN; tumourup-regulated CARD-containing antagonist of caspase 9) is located within the inflammatory bowel disease (IBD) 6 linkage region on chromosome 19, and is highly expressed in both monocytes and the gut epithelium. CARD8 interacts with the NACHT-LRR receptor NALP3 (also known as cryopyrin, NLRP3 or PYPAF1), and Apoptosis-associated Speck-like protein containing a CARD to form a caspase 1 activating complex termed the NALP3 inflammasome, which mediates the production and secretion of interleukin (IL)-1b in response to microbial challenge ( Figure 1) . 1, 2 . In addition to its role in the inflammasome, CARD8 is also a potent inhibitor of nuclear factor (NF)kB, and it has been suggested that 'cross-talk' occurs between CARD8, NALP3 and nucleotide-binding oligomerization domain protein 2 (NOD2, also known as CARD15) 2, 3 As overproduction of IL-1b and dysregulation of NFkB are hallmarks of Crohn's disease (CD), 4 it is not surprising that CARD8 was considered an attractive candidate risk gene for IBD immediately following the identification of IBD6. This view was re-enforced by a study that reported a significant protective effect of the minor allele of a CARD8 non-synonymous single-nucleotide polymorphism (SNP; rs2043211) in CD. 5 This SNP introduces a premature stop codon, resulting in the expression of a severely truncated protein. The variant CARD8 is unable to suppress NF-kB activity, leading to constitutive production of pro-IL-1b, which is a substrate for the NALP3 inflammasome. However, the results of subsequent CARD8 association studies have been mixed. No statistically significant association of rs2043211 with IBD was reported in Caucasian sample sets from Hungary (268 IBD patients, 202 controls), 6 the Netherlands (156 IBD patients, 217 controls), 6 and Norway (376 IBD patients, 365 controls), 7 or in two sample sets from Germany (sample set 1: 497 IBD, 413 controls;  6 sample  set 2: 2650 IBD patients, 1615 controls   7 ). In contrast, a significant association of CARD8 with IBD was detected in two British sample sets, but in the opposite direction to the original study, with a risk effect rather than a protective effect being observed for the minor allele of rs2043211.
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The conflicting results surrounding CARD8 rs2043211 may be explained by the presence of SNPs in other components of the inflammasome complex and within NOD2. NFkB activation, which is essential for the production of pro-IL-1b, is triggered when NOD2 detects bacterial muramyl dipeptide (Figure 1 ). Three NOD2 loss-of-function variants (rs2066844, R702W; rs2066845, G908R; rs5743294, L1007fs) that are consistently associated with CD 9 impair the activation of NFkB. 10 The argument for the existence of a synergistic interaction involving NOD2, NALP3 and CARD8 is supported by a recent study, which reported an association of CARD8 with CD only when the rs2043211 genotype was stratified for the presence of a putative gain-of-function SNP (rs35829419; Q705K) in NALP3 and the absence of the NOD2 variants (P ¼ 0.011, odds ratio (OR) ¼ 3.40, 95% confidence interval (CI) (1.32-8.76)). 11 The authors of this study proposed a model in which rs2043211 is not a significant modifier of CD risk unless it occurs in combination with rs35829419 and a wild-type NOD2 genotype. 11 In this model the truncated CARD8, encoded by rs2043211, is unable to ameliorate the activation of NFkB by NOD2, resulting in constitutive production of pro-IL-1b. The gain-of-function SNP NALP3 rs35829419 culminates in a hyper-active inflammasome with the capacity to cleave the excess pro-IL-1b, leading to overproduction of IL-1b and chronic inflammation of the gut mucosa. 11 The findings of Schoultz et al.
11 have yet to be confirmed by replication in an independent sample set. Consequently, the primary aim of our study was to genotype a New Zealand IBD sample set, 12 of known NOD2 status, for rs2043211 and rs35829419, and test for interaction between CARD8 and NALP3.
Results and discussion
The basic demographic and clinical data for the study dataset are described in Table 1 . The CARD8 SNP rs2043211 and NALP3 SNP rs35829419 did not deviate from Hardy-Weinberg equilibrium in either controls or cases (P40.05). Single-marker testing detected no association of rs2043211 with overall IBD or ulcerative colitis, but a trend towards significance was observed for CD (P ¼ 0.059, OR ¼ 0.83, 95% CI (0.69-1.01)) ( Table 2) . Furthermore, stratification of the CD patients by age of disease onset (o17, 17-40, 440 years of age), disease location (ileal, ileocolonic, colonic) and disease behaviour (non-penetrating/non-stricturing, stricturing, penetrating) revealed a protective effect of the minor allele of rs2043211 against developing CD before the age of 17 years (P ¼ 0.002, OR ¼ 0.48, 95% CI (0.29-0.78); Table 2 ), and a trend towards a protective effect against both ileal inflammation (P ¼ 0.056, OR ¼ 0.81, 95% CI (0.65-1.01) and development of stricturing and/or penetrating disease behaviour (P ¼ 0.048, OR ¼ 0.78, 95% CI (0.63-1.00)) ( Table 2 ). However, only the association of rs2043211 with early-onset disease remained significant (P ¼ 0.014) after Bonferroni correction. Additional stratification of the CD patients by NOD2 revealed no evidence for genetic interaction (P ¼ 0.854, OR ¼ 0.97, 95% CI (0.70-1.35)) ( Table 2 ). Our findings are in agreement with the study of McGovern et al., 5 in which a significantly lower frequency of the minor allele of rs2043211 was observed in CD patients with earlyonset disease (o21 years of age; P ¼ 0. Single-marker testing detected no association of NALP3 rs35829419 with overall CD, ulcerative colitis or IBD, or with CD after stratification by disease subphenotype and Figure 1 Production of interleukin (IL)-1b in response to bacterial muramyl dipeptide (MDP). MDP triggers both the activation of nucleotide-binding oligomerization domain protein 2 (NOD2) and assembly of apoptosis-associated speck-like protein (ASC) with caspase recruitment domain-containing protein 8 (CARD8), and NALP3 to form the NALP3 inflammasome. NOD2 in turn activates the transcription factor NFkB, which promotes transcription of the genes encoding pro-caspase 1 and pro-IL-1b. ASC recruits pro-caspase 1 to the inflammasome, where it is converted to caspase 1, which leads to cleavage of pro-IL-1b and secretion of mature IL-1b. 2 Genetic studies in mice have shown that IL-1b activation by muramyl dipeptide requires both NOD2 and NALP3, suggesting that these proteins may cooperate indirectly or directly to trigger an immune response.
3 CARD8 is a potent suppressor of several NF-kb activating signals and thus limits the duration of NFkB-mediated gene transcription. Loss-of-function single-nucleotide polymorphisms (SNPs) in NOD2 (rs2066844, R702W; rs2066845, G908R; rs5743294, L1007fs) also impair NFkB activation, 10 whereas loss-of-function SNP rs2043211 in CARD8 is thought to result in constitutive NFkB activity and thus in continuous production of pro-caspase 1 and pro-IL-1b.
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NOD2 genotype (all P-values 40.30) ( Table 2 ). This is in agreement with the study of Schoultz et al., 11 which also found no difference in distribution of the minor allele of this SNP across 498 Swedish controls and 742 matched controls (P ¼ 0.45, OR ¼ 1.14, 95% CI (0.82-1.58)).
Logistic regression association analysis revealed that the frequency distribution of the genotypic combinations CARD8/NALP3 1,1/1,2 and 1,2,/1,1 differed significantly across CD patients and controls (P 1,1/1,2 ¼ 0.049, OR ¼ 0.48, 95% CI (0.23-0.99); P 1,2/1,1 ¼ 0.010, OR ¼ 0.70, 95% CI (0.53-0.92)) ( Table 3 ). The strength of this protective effect increased when study participants with a variant NOD2 genotype were excluded from the analysis (P 1,1/1,2 ¼ 0.015, OR ¼ 0.35, 95% CI (0.15-0.82); P 1,2/1,1 ¼ 0.009, OR ¼ 0.66, 95% CI (0.48-0.90)) ( Table 3) . Evidence of significant overall gene-gene interaction was observed between CARD8 rs2043211 and NALP3 rs35829419, independent of NOD2 genotype (Table 3) .
After stratification of the NOD2 wild-type CD patients and controls by gender, significantly higher frequencies of the genotypic combinations CARD8/NALP3 1, 1/1,2 and 1,2,/1,1 were detected in female CD patients compared with female controls (P 1,1/1,2 ¼ 0.019, OR ¼ 0.24, 95% CI (0.10-0.79); P 1,2/1,1 ¼ 0.032, OR ¼ 0.64, 95% CI (0.42-0.96)). No association of CARD8/NALP3 with CD was detected in males (all P-values 40.177). This contrasts with the Swedish study, which detected a significant risk effect of CARD8/NALP3, but only in male CD patients with a wild-type NOD2 genotype (P ¼ 0.011; OR ¼ 3.40; 95% CI (1.32-3.42)).
No interaction of CARD8 and NALP3 was observed between Swedish controls and overall CD or in female CD patients with a All controls and patients gave their written informed consent to participate, and ethical approval for this study was obtained from the Upper South Regional Ethics Committee (New Zealand). All patients were New Zealand Caucasians, and were recruited as part of an ongoing project to investigate genetic and environmental factors that contribute to IBD aetiology. 12, 14, 15 Patients were excluded from the sample set if there was insufficient information to confirm a diagnosis of Crohn's disease (CD) or ulcerative colitis (UC). Disease in each confirmed UC and CD patient was classified according to age of diagnosis, disease location and behaviour using the Montreal Classification system. 16 The control sample set comprised unrelated New Zealand Caucasians, aged over 17 years, who had no history of inflammatory disorders.
wild-type NOD2 genotype (all P-values 40.10).
11 However, unlike our study, which assessed all but one genotypic combination of rs2043211 and rs35829419 (Table 3) , the Swedish study 11 only subdivided individuals based on the absence (CARD8/NALP3 þ / þ ) or the presence (CARD8/NALP3À/À) of at least one variant allele in both genes. It is therefore possible that this broader genotype grouping masked the interaction we observed in our unstratified sample set. Indeed, when we re-analysed our data using the genotype grouping of Schoultz et al., 11 we found no evidence of genegene interaction, regardless of NOD2 status or gender (all P values40.20).
Our logistic regression analysis has shown the existence of a significant interaction of CARD8 rs2043211 with NALP3 rs35829419 in a sample set of New Zealand Caucasians. Presence of the minor allele of one SNP with the major allele of the other SNP conferred a protective effect against CD, which intensified in the absence of the loss-of-function NOD2 mutations ( Table 3 ). The minor allele of NALP3 rs35829419 confers protection only in the context of major allele homozygosity at CARD8 rs2043211. Conversely, the minor allele of CARD8 rs2043211 confers protection only in the context of major allele homozygosity at NALP3 rs35829419. No protection is observed when the minor allele at one marker is in the presence of the minor allele at the second marker. Although this study provides no experimental data on IL-1b secretion, and thus caution must be exercised when interpreting our results, the genetic relationship we observe can be readily reconciled with the biological roles previously ascribed to NALP3, CARD8 and NOD2. The proteins interact to mediate NFkB and IL-1b production in response to bacterial muramyl dipeptide, and thus have pivotal roles in determining the strength and duration of the innate immune response 3, 13 ( Figure 1) . Presence of the minor allele of CARD8 rs2043211 is thought to result in constitutive production of pro-IL-1b, 11 but without the gain-of-function minor allele of NALP3 rs35829419 it is anticipated that this accumulation of precursor IL would not translate into the secretion of excess mature IL-1b, which is seen in active CD. It seems reasonable to also anticipate that the same net effect would be observed when the minor allele of NALP3 rs35829419 was found in combination with the major allele of CARD8 rs2043211. Without truncated Patients with CD who are heterozygous, compound heterozygous, or homozygous for NOD2 variants (rs2066844, R702W; rs2066845, G908R; rs5743294, L1007fs).
c DNA was extracted from peripheral blood samples of IBD patients and controls using guanidium isothiocyanate-chloroform. 18 Genotyping of rs2043211 and rs35829419 was performed using the pre-designed Taqman SNP genotyping assays C_25648615_10 and C_11708080_1 as per the manufacturer's instructions (Applied Biosystems, Foster City, CA, USA). The accuracy of the TaqMan was confirmed by repeat analysis of 10% of samples. Concordance between original and repeat genotype calls was 100%. NOD2 genotypes on the controls and cases sample set were available from previous studies.
14,15 A web-based calculator (http://ihg.gsf.de/cgi-bin/hw/hwa1.pl) was used to test for deviations from Hardy-Weinberg equilibrium and to conduct single-marker association tests to assess whether the MAF of rs2043211 and rs35829419 differed significantly between cases and controls. Major allele ¼ '1', minor allele ¼ '2'. d Frequency of NOD2 variants was compared within CD cases.
CARD8 and NALP3 in Crohn's disease RL Roberts et al CARD8 there would be no accumulation of pro-IL-1b, and therefore insufficient substrate for a high-activity, NALP3 rs35829419-containing inflammasome to produce and secrete the elevated amounts of IL-1b required to trigger a state of chronic inflammation in the gut mucosa.
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